Patent · US Active

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

US10138272B2 · kind B2 · utility

24Cited by
24References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 27, 2016
Grant dateNov 27, 2018
Priority date
Expiry dateDec 27, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates generally to polypeptides that include a cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator (uPA), to activatable antibodies and other larger molecules that include the cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator, and to methods of making and using these polypeptides that include a cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator in a variety of therapeutic, diagnostic and prophylactic indications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.